课题基金 / 基金详情

The research about the application of RNAi phenomenon to radiation therapy : using hSMG1-siRNA

The research about the application of RNAi phenomenon to radiation therapy : using hSMG1-siRNA
RNAi现象在放射治疗中的应用研究:使用hSMG1-siRNA
批准号:
17591284
负责人:
NAKAGAMI Yoshihiro
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

NAKAGAMI Yoshihiro的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是通过转染siRNA来敲除各种放射抵抗肿瘤的放射敏感性相关基因(ATM、hSMG 1等),改变其放射敏感性,提高放射治疗效果,为将来的基因放射治疗提供依据。放射抗性肿瘤小鼠,检测其基因产物数量的变化、生长曲线的变化及放射敏感性的变化。采用肝细胞癌移植法制备放射抗性肿瘤小鼠,采用恶性淋巴瘤移植法制备放射敏感性肿瘤小鼠。综合考虑肿瘤的粘性和宽度,确定能使肿瘤细胞凋亡而不坏死的照射剂量。我们用伽马射线照射每只小鼠。用TUNEL法检测照射前后各小鼠细胞凋亡的发生情况,用实时荧光定量PCR法检测ATM和hSMG1基因产物的数量变化。ATM和hSMG1基因产物与细胞凋亡的发生相关,另一方面,我们利用体内siRNA转染试剂,将设计好的靶向ATM和hSMG1基因的siRNA转染到肿瘤中,(TransIT In Vivo Polymer Solution),并用TUNEL法检测转染和照射前后细胞凋亡的发生,用实时荧光定量PCR方法检测ATM和hSMG1基因产物的数量变化。在ATM和hSMG 1基因敲除组中,细胞凋亡的发生减少。
英文摘要
It is the purpose of our research that we transfect siRNAs of genes about radiation sensitivity to various radiation-resistant tumor, change their radiation sensitivity, enhance radiation therapy effect and utilize this data for future gene-radiation therapy.We transfected siRNAs planed to knock down genes about radiation sensitivity (ATM, hSMG1 et.) to mice with radiation-resistant tumor, and checked the change of quantity of their gene product, the change of growth curve and the change of their radiation sensitivity We made mice with radiation-resistant tumor by transplanting hepatitis cell carcinoma, and made mice with radiation-sensitive tumor by transplanting malignant lymphoma. We considered stickiness and width of tumor and decided the radiation dose which made a proper apoptosis without necrosis on the mice. We irradiated gamma ray to each mice. We checked the occurrence of apoptosis on each mice before and after the irradiation with TUNNEL method, and checked the change of quantity of ATM and hSMG1 gene products with real-time PCR method. ATM and hSMG1 gene products correlated with the occurrence of apoptosis.On the other hand, we transfected siRNAs planed to knock down ATM or hSMG1 genes into tumors using in vivo siRNA transfection regent (TransIT In Vivo Polymer Solution), and checked the occurrence of apoptosis before and after the transfection and the irradiation with TUNNEL method, and checked the change of quantity of ATM and hSMG1 gene products with real-time PCR method. In the groups knocked down ATM and hSMG1 gene, the occurrence of apoptosis decreased.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Study on new tumor imaging by cell labelling method
  • 批准号:
    24659571
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2012
  • 负责人:
    NAKAGAMI Yoshihiro
  • 依托单位:
Study on gene expression imaging in the living body using radioilabelled siRNA
  • 批准号:
    21591572
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    NAKAGAMI Yoshihiro
  • 依托单位:
The basic research about gene-radiation therapy using DNase II gene
  • 批准号:
    15591292
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2003
  • 负责人:
    NAKAGAMI Yoshihiro
  • 依托单位:
国内基金
海外基金
基于聚(β-氨基酯)递送Roflumilast/siRNA复合体治疗MASLD相关肝纤维化的作用研究
  • 批准号:
    JCZRQNB202600554
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于多组学联合siRNA-核酸适配体技术的骨髓增生异常综合征靶向治疗研究
  • 批准号:
    2026JJ30092
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张济
  • 依托单位:
功能化破骨前体细胞膜递送双siRNA协同调控骨免疫和骨稳态改善骨质疏松的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    乔方玉
  • 依托单位:
核糖体RNA来源的siRNA通过调控翻译影 响植物干旱响应的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔洁
  • 依托单位: